Digital Therapeutics for People with Schizophrenia Spectrum Disorders: A Systematic Literature Review of Their Effect on Symptoms and Functioning
People with SSD can use DTs effectively and find them acceptable. Although effectiveness outcomes varied across/within studies, DTs may provide an acceptable strategy for delivering accessible, generally safe, evidence-based care to people with SSD.
Authors
- Daniel Fulford (ORCID: https://orcid.org/0000-0003-4405-9031)
- Philip D. Harvey (ORCID: https://orcid.org/0000-0002-9501-9366)
- Alex S. Cohen (ORCID: https://orcid.org/0000-0003-4014-6904)
- Christoph Ulrich Correll (ORCID: https://orcid.org/0000-0002-7254-5646)
Institutions
- Boston University (US)
- Louisiana State University (US)
- Feinstein Institute for Medical Research (US)
- University of Miami (US)
- University of Massachusetts Boston (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- German Centre for Cardiovascular Research (DE)
- Charité - Universitätsmedizin Berlin (DE)
- Hologic (Germany) (DE)
Publication Details
- Journal
- Schizophrenia Bulletin
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1093/schbul/sbaf134
- Citations
- 4
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.88
Funders
- Boehringer Ingelheim